Agneta Nordberg, MD, PhD from the Karolinska University Hospital Huddinge, Solna, Sweden discusses the ongoing clinical trials in Alzheimer’s disease at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. Prof. Nordberg emphasizes the importance of identifying underlaying pathologies in Alzheimer’s disease patients earlier and determining factors, such as inflammation, which contribute to early disease progression.